Alphabetical Product Listing
Product Updates
Brand to Generic
Therapeutic Class
Latex Information
Preservative Free
TALLman Labeling
Wholesale Item Numbers
TALLman Labeling
Fresenius-Kabi utilizes TALLman Labeling to help avoid medication errors associated with look-alike/sound-alike products.
Print this page Send link to a friend contactus@fresenius-kabi.com
  Product Name NDC Number Product Number Strength
C
CARBOplatin Injection 63323-172-60 107260 600 mg per 60 mL
CISplatin Injection 63323-103-51 100351 50 mg per 50 mL
CISplatin Injection 63323-103-65 100365 100 mg per 100 mL
CISplatin Injection 63323-103-64 100364 200 mg per 200 mL
D
Dilaudid® (HYDROmorphone HCl Injection, USP CII) Simplist® 76045-121-11 771311 0.2 mg per mL
Dilaudid® (HYDROmorphone HCl Injection, USP CII) Simplist® 76045-009-06 771906 0.5 mg per 0.5 mL
Dilaudid® (HYDROmorphone HCl Injection, USP CII) Simplist® 76045-009-11 771911 1 mg per mL
Dilaudid® (HYDROmorphone HCl Injection, USP CII) Simplist® 76045-010-11 771011 2 mg per mL
DimenhyDRINATE Injection, USP 63323-366-01 361601 50 mg per mL
DiphenhydrAMINE Hydrochloride Injection, USP 63323-664-01 660401 50 mg per mL
DiphenhydrAMINE Hydrochloride Injection, USP Simplist® 76045-102-10 787210 50 mg per mL
DOXOrubicin HCl Injection, USP 63323-883-05 88305 10 mg per 5 mL
DOXOrubicin HCl Injection, USP 63323-883-30 88330 50 mg per 25 mL
DOXOrubicin HCl Injection, USP 63323-101-61 100161 200 mg per 100 mL
H
hydrALAZINE Hydrochloride Injection, USP 63323-614-01 601401 20 mg per mL
HYDROmorphone Hydrochloride Injection, USP CII 63323-852-25 852101 1 mg per mL
HYDROmorphone Hydrochloride Injection, USP CII 63323-853-25 853101 2 mg per mL
HYDROmorphone Hydrochloride Injection, USP CII 63323-854-10 854101 4 mg per mL
HYDROmorphone Hydrochloride Injection, USP High Potency Formula (HPF) CII 63323-851-10 851101 10 mg per mL
HYDROmorphone Hydrochloride Injection, USP High Potency Formula (HPF) CII 63323-851-15 851105 50 mg per 5 mL
HYDROmorphone Hydrochloride Injection, USP High Potency Formula (HPF) CII 63323-851-50 851150 500 mg per 50 mL
M
methylPREDNISolone Sodium Succinate for Injection, USP 63323-265-30 276530 1 gram per vial
methylPREDNISolone Sodium Succinate for Injection, USP 63323-255-03 275503 40 mg per vial
methylPREDNISolone Sodium Succinate for Injection, USP 63323-258-03 275803 125 mg per vial
MitoXANTRONE Injection, USP (Concentrate) 63323-132-10 132010 20 mg per 10 mL
MitoXANTRONE Injection, USP (Concentrate) 63323-132-12 132012P 25 mg per 12.5 mL
S
SMOFlipid® (lipid injectable emulsion, USP), 20% for intravenous use (freeflex®) 63323-820-00 830307310 20 grams per 100 mL
SMOFlipid® (lipid injectable emulsion, USP), 20% for intravenous use (freeflex®) 63323-820-74 830570310 50 grams per 250 mL
SMOFlipid® (lipid injectable emulsion, USP), 20% for intravenous use (freeflex®) 63323-820-50 830820310 100 grams per 500 mL
SMOFlipid® (lipid injectable emulsion, USP), 20% for intravenous use (freeflex®) 63323-820-10 830920310 200 grams per 1000 mL
V
vinBLAStine Sulfate Injection 63323-278-10 27810 10 mg per 10 mL
Fresenius Kabi USA © December 2024